Advanced search
Publication Cover
Clinical and Experimental Gastroenterology Volume 10, 2017 - Issue
Submit an article Journal homepage
72
Views
8
CrossRef citations to date
0
Altmetric
Review

Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis

Robin J Dart1 Department of Gastroenterology, IBD Centre, St. Thomas’ Hospital;2 Immunosurveillance Laboratory, The Francis Crick Institute, London;3 Division of Immunology, Infection, and Inflammatory Disease (DIIID), King’s College London
,
Mark A Samaan1 Department of Gastroenterology, IBD Centre, St. Thomas’ Hospital
,
Nick Powell1 Department of Gastroenterology, IBD Centre, St. Thomas’ Hospital;4 Department of Experimental Immunobiology, Division of Transplantation and Mucosal Biology, King’s College London, London, UK
&
Peter M Irving1 Department of Gastroenterology, IBD Centre, St. Thomas’ HospitalCorrespondence[email protected]
Pages 57-66 | Published online: 03 Mar 2017

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Edward V Loftus$suffix/text()$suffix/text(), Bruce E Sands, Jean-Frédéric Colombel, Iris Dotan, Javaria Mona Khalid, David Tudor & Parnia Geransar. (2020) Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1. Clinical and Experimental Gastroenterology 13, pages 211-220.
Read now

Articles from other publishers (7)

Elena Lo Presti, Roberto Di Mitri, Filippo Mocciaro, Anna Barbara Di Stefano, Nunzia Scibetta, Elettra Unti, Giuseppe Cicero, Giulia Pecoraro, Elisabetta Conte, Francesco Dieli & Serena Meraviglia. (2019) Characterization of γδ T Cells in Intestinal Mucosa From Patients With Early-Onset or Long-Standing Inflammatory Bowel Disease and Their Correlation With Clinical Status. Journal of Crohn's and Colitis 13:7, pages 873-883.
Crossref
E L Nasonov, D I Abdulganieva & I F Fairushina. (2019) The use of Tofacitinib in the treatment of inflammatory bowel disease. Terapevticheskii arkhiv 91:2, pages 101-108.
Crossref
Philipp Schreiner, Markus F. Neurath, Siew C. Ng, Emad M. El-Omar, Ala I. Sharara, Taku Kobayashi, Tadakazu Hisamatsu, Toshifumi Hibi & Gerhard Rogler. (2019) Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More. Inflammatory Intestinal Diseases 4:3, pages 79-96.
Crossref
Mark A Samaan, Polychronis Pavlidis, Jonathan Digby-Bell, Emma L Johnston, Angad Dhillon, Ramesh Paramsothy, Abisoye O Akintimehin, Lucy Medcalf, Guy Chung-Faye, Patrick DuBois, Ioannis Koumoutsos, Nick Powell, Simon H C Anderson, Jeremy Sanderson, Bu’ Hussain Hayee & Peter M Irving. (2018) Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres. Frontline Gastroenterology 9:3, pages 221-231.
Crossref
Fábio Vieira TEIXEIRA, Adérson Omar Mourão Cintra DAMIÃO & Paulo Gustavo KOTZE. (2018) TOFACITINIB IN THE MANAGEMENT OF ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF AND ANTI-INTEGRIN THERAPIES. Arquivos de Gastroenterologia 55:2, pages 198-200.
Crossref
Neil E. McCarthy & Matthias Eberl. (2018) Human γδ T-Cell Control of Mucosal Immunity and Inflammation. Frontiers in Immunology 9.
Crossref
Manuela Moriggi, Luca Pastorelli, Enrica Torretta, Gian Eugenio Tontini, Daniele Capitanio, Stefano Ferrero Bogetto, Maurizio Vecchi & Cecilia Gelfi. (2017) Contribution of Extracellular Matrix and Signal Mechanotransduction to Epithelial Cell Damage in Inflammatory Bowel Disease Patients: A Proteomic Study. PROTEOMICS 17:23-24, pages 1700164.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.